Skip to main content
. 2019 May 7;27(6):350–354. doi: 10.1136/ejhpharm-2018-001806

Table 4.

Statistical analysis of dropouts versus non-dropouts FVC throughout time.

n Mean±SD (%) Statistical significance
FVC (%) baseline Non-dropout 14 67.64±10.40 p=0.021
Dropout 17 57.12±11.58
FVC (%) first year Non-dropout 11 76.00±18.39 p=0.005
Dropout 9 50.78±12.69
FVC (%) second year Non-dropout 6 76.00±12.44 p=0.061
Dropout 5 54.40±5.55
FVC (%) third year Non-dropout 3 86.33±16.44 p=0.400
Dropout 2 4800±11.31

Significance p<0.05 (95% CI). A dropout was a patient who discontinued pirfenidone at any time.

FVC, forced vital capacity.